JUN YONG KIM

Dr. JUN YONG KIM

Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
JUN YONG KIMJUN YONG KIM
JUN YONG KIM
WRWon-Kyu Rhim
Won-Kyu Rhim
YYYong-In Yoo
Yong-In Yoo
DKDa-Seul KIM
Da-Seul KIM
KKKyoung-Won Ko
Kyoung-Won Ko
Dong Keun HanDong Keun Han
Dong Keun Han
Exosomes derived from mesenchymal stem cells (MSCs) have been studied as vital components of regenerative medicine. Typically, various isolation methods of exosomes from cell culture medium have been developed to increase the isolation yield of exosomes. Moreover, the exosome-depletion process of serum has been considered to result in clinically active and highly purified exosomes from the cell culture medium. Our aim was to compare isolation methods, ultracentrifuge (UC)-based conventional method, and tangential flow filtration (TFF) system-based method for separation with high yield, and the bioactivity of the exosome according to the purity of MSC-derived exosome was determined by the ratio of Fetal bovine serum (FBS)-derived exosome to MSC-derived exosome depending on exosome depletion processes of FBS. The TFF-based isolation yield of exosome derived from human umbilical cord MSC (UCMSC) increased two orders (92.5 times) compared to UC-based isolation method. Moreover, by optimizing the process of depleting FBS-derived exosome, the purity of UCMSC-derived exosome, evaluated using the expression level of MSC exosome surface marker (CD73), was about 15.6 times enhanced and the concentration of low-density lipoprotein-cholesterol (LDL-c), known as impurities resulting from FBS, proved to be negligibly detected. The wound healing and angiogenic effects of highly purified UCMSC-derived exosomes were improved about 23.1% and 71.4%, respectively, with human coronary artery endothelial cells (HCAEC). It suggests that the defined MSC exosome with high yield and purity could increase regenerative activity.

16 March 2021 in ACS Nano
Verified
Journal Article
Closed access
KKKyoung-Won Ko
Kyoung-Won Ko
SPSo-Yeon Park
So-Yeon Park
ELEun Hye Lee
Eun Hye Lee
YYYong-In Yoo
Yong-In Yoo
DKDa-Seul Kim
Da-Seul Kim
Dong Keun HanDong Keun Han
Dong Keun Han

11 May 2023 in Biomaterials
Verified
Journal Article
Closed access
EREun Ji Roh
Eun Ji Roh
DKDa-Seul KIM
Da-Seul KIM
JKJun Hyuk Kim
Jun Hyuk Kim
CLChang Su Lim
Chang Su Lim
HCHyemin Choi
Hyemin Choi
In Bo HanIn Bo Han
In Bo Han

9 February 2023 in Biomaterials Research
Verified
Journal Article
Open access
PDF file
WRWon-Kyu Rhim
Won-Kyu Rhim
JUN YONG KIMJUN YONG KIM
JUN YONG KIM
SLSeung Yeon Lee
Seung Yeon Lee
SCSeung-Gyu Cha
Seung-Gyu Cha
JPJeong Min Park
Jeong Min Park
Dong Keun HanDong Keun Han
Dong Keun Han
Extracellular vesicles (EVs) are nanosized particles that are released from cells and reflect the characteristics of the mother cell. Recently, the EVs have been used in several types of studies across many different fields. In the field of EV research, multiple cell culture and EV isolation techniques have been highlighted in importance. Various strategies, including exclusive component culture media, three-dimensional (3D) cultures, and hypoxic conditions, have been proposed for the cell culture to control function of the EVs. Ultracentrifugation, ultrafiltration, precipitation, and tangential flow filtration (TFF) have been utilized for EV isolation. Although isolated EVs have their own functionalities, several researchers are trying to functionalize EVs by applying various engineering approaches. Gene editing, exogenous, endogenous, and hybridization methods are the four well-known types of EV functionalization strategies. EV engineered through these processes has been applied in the field of regenerative medicine, including kidney diseases, osteoarthritis, rheumatoid arthritis, nervous system-related diseases, and others. In this review, it was focused on engineering approaches for EV functionalization and their applications in regenerative medicine.

5 February 2020 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
KKKyoung-Won Ko
Kyoung-Won Ko
YYYong-In Yoo
Yong-In Yoo
JUN YONG KIMJUN YONG KIM
JUN YONG KIM
BCBogyu Choi
Bogyu Choi
SPSung-Bin Park
Sung-Bin Park
Dong Keun HanDong Keun Han
Dong Keun Han

9 December 2024 in ACS Nano
Verified
Journal Article
Open access
JUN YONG KIMJUN YONG KIM
JUN YONG KIM
WRWon-Kyu Rhim
Won-Kyu Rhim
SLSeung Yeon Lee
Seung Yeon Lee
JPJung Min Park
Jung Min Park
DSDuck Hyun Song
Duck Hyun Song
Dong Keun HanDong Keun Han
Dong Keun Han
Extracellular vesicles (EVs) possess the characteristics of their parent cells, based on which various studies have actively investigated treatments for diseases using mesenchymal stem cell-derived EVs due to their regenerative activity. Furthermore, in recent years, there have been significant efforts to engineer EVs to improve their native activities and integrate additional functions. Although both endogenous and exogenous methods are used for engineering EVs, endogenous methods may pose the problem of administering substances to cells undergoing metabolic changes, which can cause potential side effects. In addition, exogenous methods may have the limitation of losing beneficial factors inside EVs due to membrane disruption during engineering processes. Surface modification of EVs may also impair efficiency due to the presence of proteins on the EV surface. Therefore, in this study, a stable and efficient engineering method was achieved through the ethanol-mediated hybridization of EVs and functionalized lipid nanoparticles (LNPs) with a fusogenic lipid component. During hybridization, the internal bioactive factors and targeting moiety were maintained to possess the characteristics of both LNPs and EVs. The Ab-Hybrid, which was successfully synthesized through hybridization with nicotinamide-encapsulated and Col2A1 antibody-modified liposome and Transforming growth factor-β1 (TGF-β1)-overexpressed EVs, was administered to osteoarthritis (OA)-induced rats undergoing the destabilization of the medial meniscus surgery. Ultimately, the Ab-Hybrid demonstrated excellent chondroprotective and anti-inflammatory effects with targeting and long-lasting properties in OA lesions. We anticipate that this approach for manufacturing hybrid particles will serve as a valuable EV engineering method and a versatile platform technology applicable to various diseases.